Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, et al. “Malignant” left ventricular hypertrophy identifies subjects at high risk for progression to asymptomatic left ventricular dysfunction, heart failure, and death: MESA (multi-ethnic study of atherosclerosis). J Am Heart Assoc. 2018;7:e006619.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387–407.

Article  PubMed  CAS  Google Scholar 

Deb A. Cell-cell interaction in the heart via Wnt/beta-catenin pathway after cardiac injury. Cardiovasc Res. 2014;102:214–23.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Umbarkar P, Ejantkar S, Tousif S, Lal H. Mechanisms of fibroblast activation and myocardial fibrosis: lessons learned from FB-specific conditional mouse models. Cells. 2021;10:2412.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7:78.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin H, Li Y, Zhu H, Wang Q, Chen Z, Chen L, et al. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of beta-catenin. Cardiovasc Res. 2020;116:101–13.

Article  PubMed  CAS  Google Scholar 

Zhao Y, Wang C, Wang C, Hong X, Miao J, Liao Y, et al. An essential role for Wnt/beta-catenin signaling in mediating hypertensive heart disease. Sci Rep. 2018;8:8996.

Article  PubMed  PubMed Central  Google Scholar 

Baurand A, Zelarayan L, Betney R, Gehrke C, Dunger S, Noack C, et al. β-Catenin downregulation is required for adaptive cardiac remodeling. Circ Res. 2007;100:1353–62.

Article  PubMed  CAS  Google Scholar 

Stylianidis V, Hermans KCM, Blankesteijn WM. Wnt signaling in cardiac remodeling and heart failure. Handb Exp Pharmacol. 2017;243:371–93.

Article  PubMed  CAS  Google Scholar 

May P, Woldt E, Matz RL, Boucher P. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med. 2007;39:219–28.

Article  PubMed  CAS  Google Scholar 

Daniels TF, Killinger KM, Michal JJ, Wright RW Jr., Jiang Z. Lipoproteins, cholesterol homeostasis and cardiac health. Int J Biol Sci. 2009;5:474–88.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cheng SL, Ramachandran B, Behrmann A, Shao JS, Mead M, Smith C, et al. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals. Circ Res. 2015;117:142–56.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Z, Li Y, Wang Y, Qian J, Ma H, Wang X, et al. Cardiomyocyte-restricted low density lipoprotein receptor-related protein 6 (LRP6) deletion leads to lethal dilated cardiomyopathy partly through Drp1 signaling. Theranostics. 2018;8:627–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li J, Li C, Liang D, Lv F, Yuan T, The E, et al. LRP6 acts as a scaffold protein in cardiac gap junction assembly. Nat Commun. 2016;7:11775.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang X, Zou Y, Li Y, Chen Z, Yin C, Wang Y, et al. Lipoprotein receptor-related protein 6 is required to maintain intercalated disk integrity. Genes Cells. 2019;24:789–800.

Article  PubMed  CAS  Google Scholar 

Guo Q, Lai Y, Chu J, Chen X, Gao M, Sang C, et al. LRP6 polymorphisms is associated with sudden cardiac death in patients with chronic heart failure in the Chinese Han population. Front Cardiovasc Med. 2021;8:815595.

Article  PubMed  CAS  Google Scholar 

Wang X, Zou Y, Chen Z, Li Y, Pan L, Wang Y, et al. Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis. Theranostics. 2021;11:1249–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schonig K, Weber T, Frommig A, Wendler L, Pesold B, Djandji D, et al. Conditional gene expression systems in the transgenic rat brain. BMC Biol. 2012;10:77.

Article  PubMed  PubMed Central  Google Scholar 

Skorzynska-Dziduszko KE, Olszewska A, Prendecka M, Malecka-Massalska T. Serum heat shock protein 90 alpha: a new marker of hypertension-induced endothelial injury? Adv Clin Exp Med. 2016;25:255–61.

Article  PubMed  Google Scholar 

Yang F, Zhang Y, Zhu J, Wang J, Jiang Z, Zhao C, et al. Laminar flow protects vascular endothelial tight junctions and barrier function via maintaining the expression of long non-coding RNA MALAT1. Front Bioeng Biotechnol. 2020;8:647.

Article  PubMed  PubMed Central  Google Scholar 

Zhao S, Song TY, Wang ZY, Gao J, Cao JW, Hu LL, et al. S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3β signaling. Acta Pharmacol Sin. 2022;43:1979–88.

Article  PubMed  CAS  Google Scholar 

Mishra SJ, Khandelwal A, Banerjee M, Balch M, Peng S, Davis RE, et al. Selective Inhibition of the Hsp90alpha Isoform. Angew Chem Int Ed Engl. 2021;60:10547–51.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tayebi N, Lopez G, Do J, Sidransky E. Pro-cathepsin D, prosaposin, and progranulin: lysosomal networks in Parkinsonism. Trends Mol Med. 2020;26:913–23.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Laurent-Matha V, Derocq D, Prebois C, Katunuma N, Liaudet-Coopman E. Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. J Biochem. 2006;139:363–71.

Article  PubMed  CAS  Google Scholar 

Sha L, Chen T, Deng Y, Du T, Ma K, Zhu W, et al. Hsp90 inhibitor HSP990 in very low dose upregulates EAAT2 and exerts potent antiepileptic activity. Theranostics. 2020;10:8415–29.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong HM, Le YQ, Wang YH, Zhao HJ, Huang CW, Hu YH, et al. Extracellular heat shock protein 90alpha mediates HDM-induced bronchial epithelial barrier dysfunction by activating RhoA/MLC signaling. Respir Res. 2017;18:111.

Article  PubMed  PubMed Central  Google Scholar 

Ju S, Park S, Lim L, Choi DH, Song H. Low density lipoprotein receptor-related protein 1 regulates cardiac hypertrophy induced by pressure overload. Int J Cardiol. 2020;299:235–42.

Article  PubMed  Google Scholar 

Xue N, Du T, Lai F, Jin J, Ji M, Chen X. Secreted HSP90alpha-LRP1 signaling promotes tumor metastasis and chemoresistance in pancreatic cancer. Int J Mol Sci. 2022;23:5532.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang R, Hou X, Wang C, Li J, Zhu J, Jiang Y, et al. The endoplasmic reticulum ATP13A1 is essential for MAVS-mediated antiviral innate immunity. Adv Sci (Weinh). 2022;9:e2203831.

Article  PubMed  Google Scholar 

Lin L, Xu W, Li Y, Zhu P, Yuan W, Liu M, et al. Pygo1 regulates pathological cardiac hypertrophy via a beta-catenin-dependent mechanism. Am J Physiol Heart Circ Physiol. 2021;320:H1634–H45.